Department of Physiology, University of Maryland School of Medicine, 655 W. Baltimore St., Baltimore, MD 21201, USA.
Am J Physiol Heart Circ Physiol. 2010 May;298(5):H1472-83. doi: 10.1152/ajpheart.00964.2009. Epub 2010 Feb 19.
Mice with smooth muscle (SM)-specific knockout of Na(+)/Ca(2+) exchanger type-1 (NCX1(SM-/-)) and the NCX inhibitor, SEA0400, were used to study the physiological role of NCX1 in mouse mesenteric arteries. NCX1 protein expression was greatly reduced in arteries from NCX1(SM-/-) mice generated with Cre recombinase. Mean blood pressure (BP) was 6-10 mmHg lower in NCX1(SM-/-) mice than in wild-type (WT) controls. Vasoconstriction was studied in isolated, pressurized mesenteric small arteries from WT and NCX1(SM-/-) mice and in heterozygotes with a global null mutation (NCX1(Fx/-)). Reduced NCX1 activity was manifested by a marked attenuation of responses to low extracellular Na(+) concentration, nanomolar ouabain, and SEA0400. Myogenic tone (MT, 70 mmHg) was reduced by approximately 15% in NCX1(SM-/-) arteries and, to a similar extent, by SEA0400 in WT arteries. MT was normal in arteries from NCX1(Fx/-) mice, which had normal BP. Vasoconstrictions to phenylephrine and elevated extracellular K(+) concentration were significantly reduced in NCX1(SM-/-) arteries. Because a high extracellular K(+) concentration-induced vasoconstriction involves the activation of L-type voltage-gated Ca(2+) channels (LVGCs), we measured LVGC-mediated currents and Ca(2+) sparklets in isolated mesenteric artery myocytes. Both the currents and the sparklets were significantly reduced in NCX1(SM-/-) (vs. WT or NCX1(Fx/-)) myocytes, but the voltage-dependent inactivation of LVGCs was not augmented. An acute application of SEA0400 in WT myocytes had no effect on LVGC current. The LVGC agonist, Bay K 8644, eliminated the differences in LVGC currents and Ca(2+) sparklets between NCX1(SM-/-) and control myocytes, suggesting that LVGC expression was normal in NCX1(SM-/-) myocytes. Bay K 8644 did not, however, eliminate the difference in myogenic constriction between WT and NCX1(SM-/-) arteries. We conclude that, under physiological conditions, NCX1-mediated Ca(2+) entry contributes significantly to the maintenance of MT. In NCX1(SM-/-) mouse artery myocytes, the reduced Ca(2+) entry via NCX1 may lower cytosolic Ca(2+) concentration and thereby reduce MT and BP. The reduced LVGC activity may be the consequence of a low cytosolic Ca(2+) concentration.
使用平滑肌(SM)特异性敲除钠/钙交换体 1(NCX1(SM-/-))的小鼠和 NCX 抑制剂 SEA0400,研究了 NCX1 在小鼠肠系膜动脉中的生理作用。使用 Cre 重组酶生成的 NCX1(SM-/-)小鼠的动脉中,NCX1 蛋白表达大大降低。NCX1(SM-/-)小鼠的平均血压(BP)比野生型(WT)对照低 6-10mmHg。在 WT 和 NCX1(SM-/-)小鼠的分离、加压的肠系膜小动脉以及具有全局缺失突变(NCX1(Fx/-))的杂合子中研究了血管收缩。低 NCX1 活性表现为对低细胞外 Na+浓度、纳摩尔哇巴因和 SEA0400 的反应明显减弱。NCX1(SM-/-)动脉中的肌源性张力(MT,70mmHg)降低了约 15%,WT 动脉中的 SEA0400 也降低了相似程度。NCX1(Fx/-)小鼠的动脉中的 MT 正常,其 BP 正常。NCX1(SM-/-)动脉中的去甲肾上腺素和升高的细胞外 K+浓度引起的血管收缩明显减少。由于高细胞外 K+浓度诱导的血管收缩涉及 L 型电压门控 Ca2+通道(LVGC)的激活,我们测量了分离的肠系膜动脉心肌细胞中的 LVGC 介导的电流和 Ca2+火花。与 WT 或 NCX1(Fx/-)心肌细胞相比,NCX1(SM-/-)心肌细胞中的电流和火花都明显减少,但 LVGC 的电压依赖性失活没有增强。在 WT 心肌细胞中急性应用 SEA0400 对 LVGC 电流没有影响。LVGC 激动剂 Bay K 8644 消除了 NCX1(SM-/-)和对照心肌细胞之间 LVGC 电流和 Ca2+火花的差异,表明 NCX1(SM-/-)心肌细胞中的 LVGC 表达正常。然而,Bay K 8644 并没有消除 WT 和 NCX1(SM-/-)动脉之间肌源性收缩的差异。我们得出结论,在生理条件下,NCX1 介导的 Ca2+内流对维持 MT 有重要贡献。在 NCX1(SM-/-)小鼠动脉心肌细胞中,通过 NCX1 减少的 Ca2+内流可能降低细胞浆 Ca2+浓度,从而降低 MT 和 BP。LVGC 活性降低可能是由于细胞浆 Ca2+浓度低的结果。